Related by context. All words. (Click for frequent words.) 80 Advanced Melanoma 80 Relapsed Refractory 78 Patients Treated With 78 Complicated Skin 78 Improves Outcomes 78 Prolongs Survival 78 Cutaneous T 78 Adjuvant Chemotherapy 77 Hormone Refractory Prostate Cancer 77 Renal Cell Carcinoma 77 Pooled Analysis 77 Previously Untreated 77 Advanced Renal Cell 76 Previously Treated 76 Adjuvant Treatment 76 Metastatic Colorectal Cancer 76 Improve Survival 76 Meets Primary Endpoint 76 Chronic Sinusitis 76 Investigational Treatment 76 Malignant Melanoma 76 Metastatic Renal Cell Carcinoma 76 Phase 2b Clinical Trial 76 Metastatic Prostate Cancer 76 Anthracycline 75 Newly Diagnosed Multiple Myeloma 75 Chronic Hepatitis C 75 Myelodysplastic Syndromes 75 Diffuse Large B 75 Improved Survival 75 Chronic Lymphocytic Leukemia 75 Hepatocellular 75 Antitumor Activity 75 Shows Promise Against 75 Chronic HCV 75 Improves Survival 75 Bone Metastases 75 Appears Safe 75 Rheumatoid Arthritis Patients 75 Mouse Model 75 Advanced Prostate Cancer 75 Patients Receiving 75 Follicular Lymphoma 75 Squamous 75 Castration Resistant Prostate Cancer 74 Anti Tumor Activity 74 Unresectable 74 Severe Sepsis 74 Treatment Reduces 74 Patients Undergoing 74 Chemoradiation 74 Adjunctive Therapy 74 Oral Fingolimod 74 Androgen Deprivation Therapy 74 Peginterferon Alfa 2a 74 Secondary Hyperparathyroidism 74 CYT# potent vascular disrupting 74 Relapsing Remitting Multiple Sclerosis 74 Leukemias 74 Inhaled Corticosteroids 74 Advanced Colorectal Cancer 74 Is Well Tolerated 74 Breast Cancer Recurrence 74 Prophylactic Treatment 74 Refractory Hodgkin Lymphoma 74 Study Evaluating 74 Chronic Lymphocytic Leukemia CLL 74 Well Tolerated 74 Elderly Patients 74 HER2 Positive 74 Node Positive 74 metastatic malignant 74 Brain Metastases 74 Paraplatin ® 74 Mg Uk 73 HER2 Positive Breast Cancer 73 Treatment Shows Promise 73 Squamous Cell Carcinoma 73 Myeloma Patients 73 Resistant Hypertension 73 Orally Active 73 Survival Benefit 73 Postmenopausal Women 73 Peginterferon 73 Slow Progression 73 Shows Efficacy 73 Chronic Myeloid Leukemia 73 Advanced Ovarian Cancer 73 Metastatic Melanoma 73 Treating Chronic 73 Trial Evaluating 73 Drug Candidate 73 FDA Approves Drug 73 Patients Treated 73 Chronic Myelogenous Leukemia 73 Long Term Efficacy 73 Lung Cancer Patients 73 Drug Shows Promise 73 Tyrosine Kinase Inhibitors 73 Diabetic Foot Ulcer 73 Autologous Stem Cell Transplantation 73 Receives Orphan Drug Designation 73 Genes Predict 73 Liver Metastases 73 Phase 2b Study 72 Hepatitis C Genotype 72 Subgroup Analysis 72 Ovarian Cancer Patients 72 Combination Treatment 72 Gastric Cancer 72 Carotid Stenting 72 Clinical Outcome 72 Neuroendocrine Tumors 72 Metastases 72 Naive Patients 72 Disease Progression 72 Phase 2b Trial 72 Cyclophosphamide 72 Renal Function 72 Knee Osteoarthritis 72 Metastatic Pancreatic Cancer 72 Novel Oral 72 Slows Progression 72 Postmenopausal Osteoporosis 72 Gene Mutation 72 Clinical Trial Results 72 Minimally Invasive Treatment 72 Treatment Naive Patients 72 Partial Onset Seizures 72 Infected Patients 72 See CLINICAL PHARMACOLOGY 72 Adjuvant Therapy 72 Chronic Hepatitis B 72 Enlarged Prostate 72 Proves Effective 72 Hsp# Inhibitor 72 Critically Ill Patients 72 Sustained Efficacy 72 Reduces Mortality 72 Diabetic Neuropathy 72 Chronic Renal Failure 72 Treated Patients 72 ORLive Presents 72 Basal Cell 72 Relapsing Multiple Sclerosis 72 Diabetic Nephropathy 72 Randomized Phase II 72 Gene Linked 72 FDA Okays 72 Newly Diagnosed 72 Tyrosine Kinase Inhibitor 72 Invasive Breast Cancer 72 Atypical Hemolytic Uremic Syndrome 71 Immune Responses 71 Hemolysis 71 Phase III Clinical Trial 71 Myelodysplastic Syndrome MDS 71 Lupus Nephritis 71 Endometrial Cancer 71 Prostatic 71 Teva Provides Update 71 Papillary 71 Systemic Sclerosis 71 metastatic GIST 71 Juvenile Idiopathic Arthritis 71 Hemodialysis Patients 71 Overactive Bladder 71 Plus Ribavirin 71 Mitral Regurgitation 71 Fludarabine 71 Phase IIb Trial 71 Unfractionated Heparin 71 Progressive Multifocal Leukoencephalopathy 71 Completes Patient Enrollment 71 Lowers Risk 71 Prospective Randomized 71 Increased Mortality 71 Anti Tumor 71 Breast Cancers 71 Drug Combo 71 Combination REOLYSIN R 71 Transdermal Patch 71 TO AVOID PREGNANCY WHILE 71 Decitabine 71 Renal Impairment 71 Orthostatic Hypotension 71 Radical Prostatectomy 71 relapsed MM 71 Pegylated Interferon 71 Fluorouracil 71 Adenoma 71 Demonstrates Positive 71 Carcinomas 71 Successfully Treated 71 Prostate Cancer Patients 71 Investigational Agent 71 Bosutinib 71 Pediatric Patients 71 Recombinant Human 71 Pivotal Phase III 71 Localized Prostate Cancer 71 ST Segment Elevation 71 dasatinib Sprycel ® 71 Chronic Pelvic Pain 71 Randomized Double Blind 71 Novel Antibiotic 71 Serious Infections 71 Advanced Solid Tumors 71 Vertebral Compression Fractures 71 Combo Therapy 71 Targeted Therapy 71 Hormone Receptor Positive 71 Basal Cell Carcinoma 71 Bone Fractures 71 Spinal Fusion 71 ST Elevation Myocardial 71 papillary renal cell carcinoma 71 TNF Tumor Necrosis Factor 71 Antigen Specific 71 Fast Track Status 71 BCG refractory carcinoma 71 Granted Orphan Drug 71 Shows Promising 71 Benign Prostatic Hyperplasia 71 Ischemic Stroke 71 Patients Suffering 71 Pemetrexed 71 Relapsed Multiple Myeloma 71 Statistically Significant 71 Meta Analysis 71 refractory chronic lymphocytic 71 J Am Coll 71 Renal Artery 70 Oral Anticoagulant 70 Fungal Infections 70 NICE Recommends 70 stage IIIB 70 Hepatocellular Carcinoma 70 Interferon Beta 70 Monotherapy 70 Minimally Invasive Procedure 70 Cardiotoxicity 70 Reduces Pain 70 Plaque Psoriasis 70 Mg Usa 70 Stomach Cancer 70 Cell Lymphoma 70 Diabetic Patients 70 Efficacy Trial 70 Double Blind Placebo 70 Kidney Function 70 Lymphocytic 70 nonmetastatic 70 Relapsed 70 Chronic Heart Failure 70 Rheumatoid 70 Files IND 70 Acute Renal Failure 70 Bladder Cancer 70 LHRH receptor positive 70 Myelodysplastic Syndrome 70 metastatic pancreatic 70 Lymph Node 70 Respiratory Distress 70 Hypercholesterolemia 70 cisplatin gemcitabine 70 R Saizen R 70 Bronchiectasis 70 Cognitive Impairment 70 NMIBC 70 Relapsed Refractory Multiple Myeloma 70 Cervical Dysplasia 70 biliary tract cancer 70 Bipolar Mania 70 Adenomas 70 Effectively Treats 70 Treatment Naive 70 Novel Inhibitor 70 Single Dose 70 Fludara ® 70 Oral Cladribine 70 Radiofrequency Ablation 70 Drug Prevents 70 Treatment Experienced 70 Phase IIb Clinical Trial 70 Disease Modifying 70 Severe Asthma 70 Genital Warts 70 Pharmacokinetic Study 70 Pharmacokinetics PK 70 receiving chemoradiation therapy 70 Oral Calcitonin 70 Phase III Trial 70 Immunomodulatory 70 Vidaza ® 70 Artery Disease 70 Cervical Dystonia 70 Nucleoside 70 Premenopausal Women 70 Antidepressants Linked 70 Allogeneic 70 Renal Anemia 70 Lung Tumors 70 Lymphoid 70 Maven Semantic 70 Hypertensive Patients 70 Study Shows Promise 70 Protease Inhibitors 70 TNF Blockers 70 Neovascular Age Related Macular 70 Therapy Improves 70 Fracture Risk 70 Endometrial 70 Investigational Compound 70 Initiate Phase 70 Growth Hormone Deficiency 70 Allergic Rhinitis 70 Sipuleucel T 70 Randomized Study 70 Initiates Clinical Trial 70 chronic eosinophilic leukemia 70 erlotinib Tarceva ® 70 Lung Cancer Trial 70 Ribavirin causes 70 Antiviral Therapy 70 Prognostic Factors 70 basal cell carcinoma BCC 70 Treatment Regimen 70 Breast Cancer Patients 70 Aneurysm Repair 70 HCV Protease Inhibitor 70 Demonstrates Potent 70 vincristine doxorubicin 70 complement inhibitor eculizumab 70 Valvular 70 Colorectal Adenomas 70 intravesical infusion therapy 70 Multiple Myeloma Patients 70 Genes Linked 70 receptor tyrosine kinase inhibitor 70 Heart Failure Patients 70 Completes Enrollment 70 Depressive Symptoms 70 Carboplatin Paclitaxel 70 Vertebral Fractures 70 Obesity Linked 70 Skeletal Muscle 70 Predict Risk 70 Novel Treatments 70 Epratuzumab 70 Dose Finding 70 Malignant Glioma 70 Respiratory Virus 70 Nilotinib 70 PEGINTRON TM 70 Hypertrophy 70 Test Detects 70 Migraine Treatment 70 Pegylated Liposomal Doxorubicin 70 Squamous Cell 70 Myelofibrosis 70 Atypical Antipsychotics 70 Unstable Angina 70 Colorectal Cancer Patients 70 myelodysplastic myeloproliferative diseases 70 Renal Cancer 69 Gastrointestinal Stromal Tumors 69 thalidomide Thalomid 69 Kinase Inhibitor 69 Genetic Variant 69 Cell Transplants 69 metastatic gastric 69 Aflibercept 69 Chronic Prostatitis 69 Venous Thromboembolism 69 Migraine Headaches 69 Protease Inhibitor 69 Kinase Inhibitors 69 Boosts Survival 69 Safinamide 69 Aurora Kinase 69 Solid Malignancies 69 Demonstrates Efficacy 69 Arterial Disease 69 Paroxysmal Nocturnal Hemoglobinuria PNH 69 Contrast Agents 69 ACE Inhibitors 69 IND Application 69 Phase IIa Clinical Trial 69 External Beam 69 Esophageal 69 Newly Diagnosed Breast Cancer 69 Causes Symptoms 69 Hepatic Encephalopathy 69 NASH Huntington 69 Clinical Trial Evaluating 69 Demonstrates Potential 69 Peginterferon alfa 2b 69 Patient Enrollment 69 Chemotherapy Induced 69 Albuferon TM 69 Rectal Cancer 69 Adjunctive 69 Prostate Cancer Vaccine 69 Anthrax Toxin 69 Often Misdiagnosed 69 Renal Cell Cancer 69 Lenalidomide 69 Acute Ischemic Stroke 69 Neoadjuvant 69 Phase 2a Clinical Trial 69 Inhaled Nitric Oxide 69 Cancer Patients Treated 69 haematologic 69 Thrombotic 69 Attenuates 69 arthritis PsA 69 Virus Linked 69 Atopic Dermatitis 69 Prostate Biopsy 69 Iron Overload 69 Randomized Double blind 69 Autoimmune Disease 69 Levels Linked 69 Generalized Anxiety Disorder 69 Chronic Constipation 69 Inflammatory Markers 69 Ischemic 69 Intracerebral Hemorrhage 69 Oral Mucositis 69 R lenalidomide 69 Amgen Neulasta R 69 Posaconazole 69 Osteoporosis Treatment 69 Non Invasive Treatment 69 Endothelial Cells 69 Statin Therapy 69 Treatment Naïve Patients 69 Versus Placebo 69 Replacement Therapy 69 Advanced Pancreatic Cancer 69 Controlled Study 69 Acute Exacerbations 69 Paroxysmal Nocturnal Hemoglobinuria 69 Diabetic Ulcers 69 Capecitabine 69 Uterine Cancer 69 B Cell Lymphoma 69 Demonstrates Significant 69 metastatic colorectal 69 Dose Ranging Study 69 Muscle Wasting 69 Mimetics 69 Investigational Drug 69 Mantle Cell Lymphoma 69 Glioblastoma Multiforme 69 Brain Atrophy 69 Lung Cancer Survival 69 Pharmacologic 69 subependymal giant cell 69 REMINDER ORLive Presents 69 Rheumatoid Arthritis RA 69 Osteoporosis Drugs 69 Philadelphia Chromosome Positive 69 Successfully Treats 69 Randomized Phase 69 Phase 2a Trial 69 Soft Tissue Sarcomas 69 Treatment Resistant 69 SPRYCEL ® 69 Crit Rev 69 kidney urologic 69 myocardial infarction ventricular fibrillation 69 Mouse Models 69 oropharyngeal candidiasis OPC 69 Beta Blocker 69 Dose Escalation Study 69 Protein Linked 69 Preclinical Models 69 Peginterferon Alfa 2b 69 Smoking Linked 69 Non Responders 69 Community Acquired Pneumonia 69 Less Invasive 69 Neoplasms 69 Gene Variant 69 Clostridium difficile Infection 69 Placebo Controlled Study 69 Acute Pancreatitis 69 Gene Variation 69 lenalidomide Revlimid R 69 Anticancer Drugs 69 included exfoliative dermatitis 69 Initiate Clinical Trial 69 Post Operative 69 severe oral mucositis 69 Recurrent Glioblastoma 69 leiomyomas 69 HCV Genotype 69 Adenocarcinoma 69 essential thrombocythemia ET 69 Vulvar 69 Poorly Controlled 69 Medullary Thyroid Cancer 69 Polyneuropathy 69 Newly Diagnosed Patients 69 Thyroid Cancer 69 Epilepsy Drugs 69 Dupuytren Disease 69 Genes Identified 69 Endocrinol 69 Aggressive Prostate Cancer 69 Significantly Reduced 69 Prolongs Life 69 RNAi Therapeutic 69 Potentially Fatal 69 Efficacious 69 Pre Cancerous 69 Surgical Procedures 69 Anticancer Drug 69 infliximab monotherapy 69 NCCN Updates 69 Neoadjuvant Chemotherapy 69 Uterine Fibroids 69 familial amyloidotic polyneuropathy FAP 69 II Clinical Trial 69 Enzyme Replacement Therapy 69 Intravenous Formulation 69 Skin Structure Infections 69 Study Showed 69 Submits NDA 69 Relapsed Refractory Aggressive 69 Parathyroid Hormone 69 Left Ventricular Hypertrophy 69 Fulvestrant 69 Tigecycline 69 Beneficial Effects 69 Treat Heart Failure 69 refractory NSCLC 69 Chronic lymphocytic leukemia 69 Malignancies 69 chemotherapy cisplatin 69 Irinotecan 69 hypertrichosis occurred 69 Cardiovascular Events 69 overactive bladder syndrome 69 Clinical Efficacy 69 5 fluorouracil leucovorin 69 Systemic Delivery 69 J Shoulder Elbow 69 Epidermal Growth Factor Receptor 69 C1 Inhibitor 69 Pulmonary Arterial Hypertension 69 Pivotal Study 69 Progenitor Cells 69 Drug Resistant 69 Stage IIB 69 bone marrow reticulin deposition 69 fallopian tube carcinoma 69 Humanized Anti 69 Inflammatory Disease 68 Azacitidine 68 Monoclonal Antibody 68 Ozarelix 68 recurrent glioblastoma multiforme 68 ergot derivatives 68 atypical Hemolytic Uremic Syndrome 68 Diabetic Neuropathic Pain 68 IIa Clinical Trial 68 Inflammatory Pain 68 pralatrexate injection folate analogue 68 Hepatitis C Virus 68 FDA Approvals 68 induce orthostatic hypotension 68 Ovarian Cancers 68 Tumor Response 68 See WARNINGS 68 alfa 2a 68 Cholesterol Lowering Drug 68 MEK Inhibitor 68 Temodar ® 68 HDAC Inhibitor 68 Antiangiogenic 68 Adenoviral 68 Acute Bacterial Sinusitis ABS 68 rheumatoid arthritis RA psoriatic 68 Non Alcoholic Steatohepatitis 68 Nicotine Vaccine 68 Prognostic Significance 68 Hyperlipidemia 68 Therapy Shows Promise 68 FUSILEV enhances 68 Catheter Ablation 68 Septic Shock 68 Antitumor 68 Seasonal Allergic Rhinitis 68 Peripheral Arterial 68 Liver Tumors 68 Therapeutic Efficacy 68 Breast Tumors 68 Phase III Trials 68 COPEGUS R 68 ZACTIMA TM ZD# 68 Treating Heart Failure 68 Demonstrated Significant 68 Vaccine Adjuvant 68 Idiopathic Pulmonary Fibrosis 68 Predict Prostate Cancer 68 Electrical Stimulation 68 Acute Myeloid Leukaemia AML 68 Estrogen Receptor 68 hypereosinophilic syndrome 68 Vitrasert R 68 Fewer Side Effects 68 Antiviral Activity 68 recurrent metastatic 68 PEGylated Fab fragment 68 Potent Anti 68 Genetic Predisposition 68 Parathyroid 68 Obese Patients 68 Placebo Controlled Trial 68 Shows Statistically Significant 68 Spinal Fractures 68 Autoimmune Diseases 68 Multiple Myeloma MM 68 Coronary Arteries 68 metastatic neuroendocrine tumors 68 Breast Cancer Treatment 68 Viral Load 68 Hepatitis C Infection 68 Blood Clots 68 Present Preclinical Data 68 Non Hodgkin 68 Catheter Associated 68 Invasive Fungal Infections 68 JAK2 Inhibitor 68 Mylan Receives Approval 68 Epstein Barr Virus 68 Angioedema 68 Glufosfamide 68 Novel Compound 68 Eculizumab 68 Neovascularization 68 Receives Positive Opinion 68 Nat Rev 68 Inherited Diseases 68 Anticancer Activity 68 resistant hormone refractory 68 J Clin 68 hyperplasia BPH 68 demonstrated antitumor activity 68 Stem Cell Transplants 68 Pivotal Clinical Trial 68 Skin Cancers 68 relapsed Acute Myeloid 68 Human Neural Stem 68 Initiates Enrollment 68 moderate renal impairment 68 Cardiovascular Outcomes 68 tumor xenograft models 68 Navelbine ® 68 Preclinical Data 68 Gastric Ulcers 68 miconazole Lauriad ® 68 orally administered inhibitor 68 Medoxomil 68 Autoantibodies 68 G CSFs 68 Hypertriglyceridemia 68 Hematological Malignancies 68 Am J Obstet 68 Presents Preclinical Data 68 Bacterial Vaginosis 68 Bone Marrow Cells 68 Postherpetic Neuralgia 68 Fondaparinux 68 chemoradiation therapy 68 Hematologic 68 Carcinoma 68 Immunotherapeutic 68 somatostatin analog 68 Thromboembolism 68 Embolization 68 Beta Blockers 68 Aortic Valve 68 Male Pattern Baldness 68 CYP#A# CYP#D# 68 gastrointestinal stromal tumors GIST 68 Desvenlafaxine Succinate 68 keloid scarring 68 Colon Polyps 68 MELAS 68 Clot Busting 68 Solid Tumors 68 Female Stress Urinary 68 Vaccine Shows Promise 68 Oral Insulin 68 Subtypes 68 First Patient Dosed 68 stage IIIb IV 68 Differential Diagnosis 68 advanced metastatic renal 68 Hematopoietic 68 Anti TNF 68 Combination Therapy 68 Novel Therapeutic 68 Acute Attacks 68 Induction Therapy 68 Left Ventricular 68 Dendritic Cells 68 Treatment Naive HIV 68 Commonly Used 68 refractory cutaneous T 68 Neurol 68 Asthma COPD 68 Vaginal Gel 68 chronically immunosuppressed solid 68 Demonstrate Significant 68 Insulin Glargine 68 Abdominal Fat 68 Folfox 68 lichen planus 68 developing Bicifadine serotonin 68 oral dual endothelin 68 Prenatal Diagnosis 68 Non Alcoholic Fatty 68 LymphoStat B belimumab 68 Successfully Completes Phase 68 Tumor Growth 68 Sapacitabine 68 Hematology Molecular Pathology 68 lexidronam injection 68 J Foot Ankle 68 Immune Mediated 68 sunitinib Sutent ® 68 Randomized Clinical Trial 68 Multicenter Study 68 advanced hepatocellular carcinoma 68 Psychiatric Disorders 68 nilotinib Tasigna ® 68 leukopenia pancytopenia thrombocytopenia 68 Xeloda ® 68 Autoimmune Disorders 68 achieved CCyR 68 Lung Cancers 68 Dual Antiplatelet Therapy 68 Cancer Treatments 68 myelofibrosis polycythemia vera 68 T1c 68 unresectable stage 68 Proven Effective 68 Sezary syndrome 68 brand ciclesonide HFA 68 Epoetin Alfa 68 carcinoma mCRC 68 Sleep Disturbances 68 Int J Radiat Oncol 68 Hospital Acquired Pneumonia 68 Arch Facial Plast 68 dacarbazine DTIC 68 Thromboembolic 68 AA Amyloidosis 68 Rare Genetic 68 Tipranavir 68 Skin Disorders 68 Cystectomy 68 Prove Effective 68 Receives Orphan Drug 68 Low Dose 68 evaluating picoplatin 68 neutropenia dehydration dyspnea 68 Inflammatory Diseases 68 J Am Acad 68 biologic DMARD 68 Treat Anemia 68 Emerging Therapies 68 Skin Lesions 68 Bortezomib 68 Randomized Controlled 68 Gemcitabine 68 Migraine Headache 68 Platinol ® 68 vinca alkaloid 68 Stable Coronary Artery 68 Short Stature 68 Proc Am Soc 68 Chemotherapy induced 68 Etanercept 67 Suicidality 67 Doxil ® 67 Dupuytren Contracture 67 Myeloid 67 treat benign prostatic 67 Levoleucovorin 67 denileukin diftitox 67 Precancerous 67 Surgical Treatment 67 Chronic Bronchitis 67 Initiates Phase III 67 GW# [003] 67 Stomatitis 67 Investigational Oral 67 Tolerability 67 Liver Injury 67 Urinary Incontinence 67 Reduced Risk 67 Bayer HealthCare Onyx Pharmaceuticals 67 Predict Response 67 Regenerative Cell 67 Multicenter Trial 67 Primary Hypercholesterolemia 67 J Cataract Refract 67 Randomized Clinical Trials 67 Liver Failure 67 Non Melanoma Skin 67 DEB# 67 Bazedoxifene 67 Hip Fractures 67 Stress Urinary Incontinence 67 urothelial carcinoma 67 Nonalcoholic fatty liver 67 JAK Inhibitor 67 relapsed leukemia 67 Hepatitis B Virus 67 Multiple Sclerosis Rheumatoid Arthritis 67 Topical Treatment 67 significant cytopenia eg 67 Contrast Agent 67 ® lenalidomide 67 Etiology 67 Cell Non Hodgkin 67 topically administered 67 Degarelix 67 Aeolus Pharmaceuticals Announces 67 novel emulsion formulation 67 Cytarabine 67 Leucovorin 67 Randomized Controlled Trials 67 Dose Escalation 67 Heterozygous Familial Hypercholesterolemia 67 Xenografts 67 Toxicities 67 Bullous 67 MAGE A3 ASCI 67 Kidney Transplant Patients 67 Non Inferiority 67 Bare Metal Stent 67 Gene Mutation Linked 67 Chemotherapy Improves 67 ErbB2 positive 67 Randomized Trials 67 Effective Than 67 Zorbtive TM 67 Natalizumab 67 Hormone Replacement 67 Bronchopulmonary Dysplasia 67 Free Full Text 67 Cardiac Resynchronization 67 Recurrent Ovarian Cancer 67 Hormone Therapy 67 vinorelbine tartrate 67 Mycophenolate Mofetil 67 Hepatocellular Carcinoma HCC 67 Isavuconazole 67 Endothelial Function 67 situ CIS 67 Breast conserving 67 Prostate Cancer Progression 67 FDA Clears 67 Endovascular Treatment 67 Oral Cavity 67 Stent Placement 67 Expanded Indication 67 Hyperkalemia 67 Pivotal Phase 67 Adefovir 67 Systemic lupus erythematosus SLE 67 Bucindolol Based 67 Viral Infection 67 Cognitive Deficits 67 Cytotoxicity 67 docetaxel Taxotere ® 67 Retreatment 67 BARACLUDE ® 67 erythematosus 67 Lanthanum Carbonate 67 Pegylated 67 imatinib Gleevec ® 67 Previously Untreated Multiple Myeloma 67 ara C 67 Pegloticase 67 DOXIL 67 Cocaine Addiction 67 topical gel formulation 67 completely resected 67 rheumatoid arthritis systemic lupus 67 Cardiol 67 endoluminal stent graft 67 Smooth Muscle 67 Genes Associated 67 Cancer Incidence Mortality 67 Neurogenic 67 Predict Breast Cancer 67 DOXIL ® 67 Antifungal 67 TAXOTERE R 67 Respiratory Syncytial Virus 67 Confirmatory Phase 67 Soy Isoflavones 67 Osteoporosis Drug 67 Leukemia AML 67 Valvular Heart Disease 67 Experimental Vaccine 67 Pivotal Trial 67 PEGylated anti 67 Melphalan 67 Dermatol 67 Prostate Cancers 67 PEG IFN 67 Candidiasis 67 Benign Prostatic Hyperplasia BPH 67 ThermoDox R 67 Cardiovascular Disease Risk 67 gemcitabine carboplatin 67 Colorectal Cancers 67 Cilostazol 67 Gentium Announces 67 Benign prostatic hyperplasia BPH 67 Temsirolimus 67 Post Menopausal 67 cutaneous squamous cell carcinoma 67 Anticoagulant 67 ritonavir boosted 67 Acne Rosacea 67 Aspirin Reduces 67 INSPIRE Trial Phase III 67 iobenguane 67 Sevelamer 67 Systemic lupus erythematosus 67 Paclitaxel Carboplatin 67 Metastatic Disease 67 sarcoma melanoma 67 Glucocorticoid 67 ceftazidime 67 Intracranial Aneurysms 67 Mutational 67 Bivalirudin 67 Brain Tumors 67 including eniluracil ADH 67 Initiates Phase II 67 cell lymphoma CTCL 67 Nitazoxanide 67 Intravesical 67 Fixed Dose 67 Perifosine KRX 67 Venous Thrombosis 67 Stem Cell Treatment 67 concomitant cardiac 67 Patient Treated 67 Osteomyelitis 67 dasatinib Sprycel 67 Develop Novel 67 Nat Clin Pract 67 Nebulized 67 EGFR TKI 67 Taxane 67 Cyclooxygenase 2 67 Gene Mutations 67 Dementia Related Psychosis 67 Carcinoid Syndrome 67 histological subtype 67 Diabetic Foot Ulcers 67 Tezampanel 67 Schizoaffective Disorder 67 Lowers Blood Pressure 67 Myocardial Ischemia 67 Brentuximab Vedotin SGN 67 Thiazolidinediones 67 Tumor Necrosis Factor 67 sorafenib tablets 67 Gemzar ® 67 IMiDs ® 67 Lung Cancer Drug 67 Sandostatin R 67 mg q#h 67 #-# Full Text 67 Kit CD# positive 67 recurrent NSCLC 67 Genetic Tests 67 Strongly Linked 67 acyclovir Lauriad R 67 Acute Bacterial Skin 67 Varicose Veins 67 Preclinical Study 67 Inflammatory Arthritis 67 Premature Infants 67 Laryngeal Cancer 67 TRIOLEX HE# APOPTONE HE#